Advances in skin gene therapy.
Specific anatomical and biological properties make the skin a very interesting target organ for gene therapy approaches. Different cell types of the epidermis, such as keratinocytes, melanocytes, or dendritic cells, can be genetically modified to treat a broad spectrum of diseases, including genetically inherited skin disorders, tumour diseases, metabolic disorders and infectious diseases. The easy accessibility of skin suggests that different methods for gene delivery can be pursued, depending on the desired application. The approach used to deliver DNA to the skin will influence not only the efficiency of DNA delivery, but also the level and duration of transgene expression. Furthermore, the desired biological effect will also influence the decision of which gene transfer method is the best choice. Among the current challenges of cutaneous gene therapy are: optimising the efficiency of direct in vivo gene delivery; targeting specific epidermal cells, including keratinocyte stem cells; achieving sustained gene expression and regulating gene expression in vivo. This review summarises recent advances in the field of skin gene therapy and evaluates possible strategies to overcome obstacles and achieve successful clinical applications of skin gene therapy.
Pfützner
W
W
National Institute of Health, Dermatology Branch, National Cancer Institute, 6130 Executive Blvd, Bethesda, MD 20892-1908, USA. pfutzner@box-p.nih.gov
Vogel
J C
JC
D000818:Animals; D015870:Gene Expression / Q000276:immunology; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics / Q000627:therapeutic use*; D006801:Humans; D012871:Skin Diseases / Q000628:therapy*; D014162:Transfection / Q000379:methods; D019076:Transgenes / Q000276:immunology; D019444:Vaccines, DNA / Q000235:genetics / Q000627:therapeutic use*
D019444:Vaccines, DNA